Skip to main content
    O

    OSR Holdings Inc (OSRH)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.11
    +0.01 (+13.10%)

    Market Cap: $7.90M

    Last updated: Nov 13, 2026 at 4:00 PM ET

    OSR Holdings Inc (OSRH) Competitors

    Updated Nov 13, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to OSR Holdings are Kiora Pharmaceuticals (KPRX), Cardio Diagnostics Holdings (CDIO) and Reviva Pharmaceuticals Holdings (RVPH). By market cap, OSR Holdings ranks 5th of the 13 companies on this page; OS Therapies (OSTX) is the largest at $34.87M.

    Peer Comparison

    OSRH's ROIC of -11.0% is above the peer median of -175.4%, and its revenue growth of -72.2% is below the median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    OSR Holdings (OSRH)$7.90MN/A2.3x0.0%-11.0%-72.2%0.00%
    Kiora Pharmaceuticals Inc (KPRX)$5.44MN/A6.2x0.0%N/A0.0%0.00%
    Cardio Diagnostics Holdings Inc (CDIO)$5.59MN/A348.9x0.0%N/A25.7%0.00%
    Reviva Pharmaceuticals Holdings Inc. (RVPH)$4.63MN/AN/A0.0%-90.2%0.0%0.00%
    SeaStar Medical Holding Corporation (ICU)$4.46MN/A1.7x0.0%N/A82.0%0.00%
    Neurosense Therapeutics Ltd (NRSN)$3.21MN/AN/A0.0%N/A0.0%0.00%
    OS Therapies Incorporated (OSTX)$34.87MN/AN/A0.0%218.0%0.0%0.00%
    MetaVia Inc. (MTVA)$8.56MN/AN/A0.0%N/A0.0%0.00%
    Ensysce Biosciences Inc (ENSC)$8.14MN/A1.2x-280.5%-260.6%-15.1%0.00%
    Soligenix Inc. (SNGX)$7.50MN/AN/A0.0%N/A-100.0%0.00%
    Tempest Therapeutics Inc (TPST)$7.64MN/AN/A0.0%-783.6%0.0%0.00%
    Jasper Therapeutics Inc (JSPR)$15.18MN/A1.6x0.0%N/A0.0%0.00%
    FibroBiologics, Inc. Common Stock (FBLG)$6.57MN/AN/A0.0%N/A0.0%0.00%
    Peer median$7.03MN/A1.7x0.0%-175.4%0.0%0.00%
    Market data as of Nov 13, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to OSR Holdings, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Kiora Pharmaceuticals Inc (KPRX)
    Kiora Pharmaceuticals Inc. is a clinical-stage biotechnology firm focused on developing innovative therapies for ocular diseases and neurodegenerative...
    KPRX competitors
    Cardio Diagnostics Holdings Inc (CDIO)
    Cardio Diagnostics Holdings Inc (CDIO) is a pioneering biotechnology firm focused on enhancing cardiovascular health through innovative diagnostic solutions.
    CDIO competitors
    Reviva Pharmaceuticals Holdings Inc. (RVPH)
    Reviva Pharmaceuticals Holdings Inc. (RVPH) is a clinical-stage biopharmaceutical company dedicated to developing groundbreaking therapies for central nervous...
    RVPH competitors
    SeaStar Medical Holding Corporation (ICU)
    SeaStar Medical Holding Corporation (ICU) is a forward-looking biotechnology company dedicated to innovating treatment solutions for chronic kidney disease via...
    ICU competitors
    Neurosense Therapeutics Ltd (NRSN)
    Neurosense Therapeutics Ltd (NRSN) is a clinical-stage biotechnology firm dedicated to innovating treatments for neurodegenerative diseases...
    OS Therapies Incorporated (OSTX)
    OS Therapies Incorporated is a pioneering biopharmaceutical company committed to developing innovative treatments for unmet medical needs...
    OSTX competitors
    MetaVia Inc. (MTVA)
    MetaVia Inc. is an innovative technology company dedicated to delivering advanced digital solutions that enhance connectivity and productivity across multiple...
    MTVA competitors
    Ensysce Biosciences Inc (ENSC)
    Ensysce Biosciences, Inc., a clinical-stage biotechnology company, is dedicated to the development of various prescription drugs.
    ENSC competitors
    Soligenix Inc. (SNGX)
    Soligenix, Inc., an advanced stage biopharmaceutical company, focuses on developing and marketing products to treat rare diseases in the United States.
    SNGX competitors
    Tempest Therapeutics Inc (TPST)
    Tempest Therapeutics Inc., a clinical-stage oncology company, is dedicated to the development of small molecules that combine targeted and immune-mediated...
    TPST competitors
    Jasper Therapeutics Inc (JSPR)
    Jasper Therapeutics Inc (JSPR) is a pioneering biopharmaceutical company dedicated to advancing hematopoietic stem cell therapies aimed at improving treatment...
    JSPR competitors
    FibroBiologics, Inc. Common Stock (FBLG)
    FibroBiologics, Inc. is an innovative biotechnology company dedicated to advancing regenerative medicine through its proprietary fibroblast cell technology...
    FBLG competitors

    Frequently Asked Questions About OSRH

    Who are OSR Holdings' main competitors?

    The companies most similar to OSR Holdings include Kiora Pharmaceuticals (KPRX), Cardio Diagnostics Holdings (CDIO), Reviva Pharmaceuticals Holdings (RVPH), SeaStar Medical Holding (ICU) and Neurosense Therapeutics (NRSN), listed from the closest match.

    Who is OSR Holdings' biggest competitor?

    OS Therapies (OSTX) is the largest of the similar companies at $34.87M; Kiora Pharmaceuticals (KPRX) is the closest match by business profile, size, sector and industry.

    How does OSRH stock compare with its competitors?

    OSRH's P/S is 2.3x against a peer median of 1.7x; its net margin is 0.0% against a peer median of 0.0%.

    Which of OSR Holdings' competitors pays a higher dividend?

    OSR Holdings pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is OSR Holdings bigger than its competitors?

    No. OSR Holdings is 5th by market cap among the 13 companies on this page; the largest is OS Therapies (OSTX) at $34.87M.